Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.75
2
NAV
₹10.99
₹582.47
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
₹322.43 Cr
₹4997.72 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
16.15%
3 Year
-
23.46%
5 Year
-
16.78%
Equity
96.71%
97.16%
Cash
3.29%
2.78%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.11% |
Apollo Hospitals Enterprise Ltd. | 8.08% |
Cipla Ltd. | 6.82% |
Max Healthcare Institute Ltd. | 6.30% |
Divi's Laboratories Ltd. | 6.12% |
JB Chemicals & Pharmaceuticals Ltd. | 4.27% |
Dr. Reddy's Laboratories Ltd. | 4.21% |
Aurobindo Pharma Ltd. | 3.92% |
Glenmark Pharmaceuticals Ltd. | 3.42% |
Dr. Lal Pathlabs Ltd. | 2.96% |
Sun Pharmaceutical Industries Ltd. | 11.18% |
Acutaas Chemicals Ltd. | 6.35% |
Divi's Laboratories Ltd. | 5.92% |
Apollo Hospitals Enterprise Ltd. | 5.21% |
Max Healthcare Institute Ltd. | 5.08% |
Aurobindo Pharma Ltd. | 4.17% |
Aster DM Healthcare Ltd. | 3.77% |
Laurus Labs Ltd. | 3.64% |
Cipla Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999
